In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders (Record no. 48509)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01844nam a2200265Ia 4500 |
000 - LEADER | |
fixed length control field | 02106naaa 00301uu |
001 - CONTROL NUMBER | |
control field | https://directory.doabooks.org/handle/20.500.12854/50090 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20211222135534.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 211013s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781789857177 |
024 ## - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.5772/intechopen.72962 |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Houria Bachtarzi |
245 #0 - TITLE STATEMENT | |
Title | In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | IntechOpen |
Date of publication, distribution, etc. | 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 electronic resource (198 p.) |
506 ## - RESTRICTIONS ON ACCESS NOTE | |
Terms governing access | Open Access |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Ongoing advances in pharmaceutical biotechnology have paved the way to ground-breaking new biological therapeutic modalities, offering the possibility of a durable curative approach for a number of life-threatening diseases, for which the medical need is as yet unmet. Over the past decades, gene therapy has seen a massive transformation from a proof-of-concept approach to a clinical reality culminating in the regulatory approval of state-of-the-art products in the European Union and in the United States. This book captures some of the scientific progresses notably in gene transfer technologies and translational development of in vivo and ex vivo gene therapy interventions in the treatment of a broad range of complex and debilitating non-inherited and inherited disorders such as: human immunodeficiency virus 1 (HIV-1) infection, cancer, cystic fibrosis, hereditary retinopathies, haemophilia B, cardiac diseases, and chronic liver fibrosis. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE | |
Terms governing use and reproduction | All rights reserved |
653 ## - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Life Sciences |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://directory.doabooks.org/handle/20.500.12854/50090">https://directory.doabooks.org/handle/20.500.12854/50090</a> |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://www.intechopen.com/books/in-vivo-and-ex-vivo-gene-therapy-for-inherited-and-non-inherited-disorders">https://www.intechopen.com/books/in-vivo-and-ex-vivo-gene-therapy-for-inherited-and-non-inherited-disorders</a> |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="www.oapen.org">www.oapen.org</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | E-Book |
Withdrawn status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|
Library of Congress Classification | Not For Loan | Directory of Open Access Books | Directory of Open Access Books | 12/22/2021 | 12/22/2021 | 12/22/2021 | E-Book |